title: How might the Trans-Pacific Partnership impact on the pharmaceutical sector in Vietnam?
abstract: Ratification of the Trans-Pacific Partnership (TPP) will attract a large number of foreign drug companies in the coming years to Vietnam. It is anticipated to bring investment to Vietnam's pharmaceutical industries, lead to increased infrastructure and enable the use of more sophisticated technologies for the discovery, development and manufacture of drugs. However, with respect to pharmaceutical companies, which are producing generic drugs primarily, the availability of biologic will be reduced. Thus, the consequence is, an increase in drug cost resulting in difficulties for patients wishing to procure these drugs. This will be particularly detrimental for developing countries, such as Vietnam and Malaysia.
authors.affiliation: Daitin & Associates, 19 Hoang Dieu, Dist. 4, Ho Chi Minh City, Vietnam.
authors.forename: Nguyen Hoa
authors.initials: NH
authors.lastname: Binh
authors.affiliation: Master of Law course S1580107, Major in Economic Law, Law Department, University of Economics and Law, Vietnam National University, 6 Quarter, Linh Trung Ward, Thu Duc District, Ho Chi Minh City, Vietnam.
authors.forename: Pham Ngoc Kieu
authors.initials: PN
authors.lastname: Anh
authors.affiliation: Ho Chi Minh City University of Food Industry, 140 Le Trong Tan, Tan Phu Dist., Ho Chi Minh City, Vietnam.
authors.forename: Nguyen Minh
authors.initials: NM
authors.lastname: Phuong
mesh_terms: D003132:Commerce; D004345:Drug Industry; D016568:Drugs, Generic; D007391:International Cooperation; D010330:Patents as Topic; D014744:Vietnam
chemical_list: D016568:Drugs, Generic
keywords: TPP; TRIPS; brand name; data exclusivity; drugs; generic; industry; market; patent; pharmaceuticals